Xia Sun

76 West Yanta Road
Xi'an, 710061, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Hepatocyte-Specific Knockout of YAP Protects Against Atherosclerosis via Inhibition of ANGPTL3 in Mice.

Hepatocyte-Specific Knockout of YAP Protects Against Atherosclerosis via Inhibition of ANGPTL3 in Mice.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: February 26, 2026

Hepatocyte-specific yes-associated protein knockout exacerbates non-alcoholic steatohepatitis by upregulating PCSK9.

Hepatocyte-specific yes-associated protein knockout exacerbates non-alcoholic steatohepatitis by upregulating PCSK9.

Journal: Journal of gastroenterology

Published: July 29, 2025

YAP-mediated macrophage polarization is involved in progression of atherosclerosis.

YAP-mediated macrophage polarization is involved in progression of atherosclerosis.

Journal: European journal of pharmacology

Published: March 16, 2025

Yes-Associated Protein in Hepatocytes Protects Against Early Alcohol-Associated Liver Disease.

Yes-Associated Protein in Hepatocytes Protects Against Early Alcohol-Associated Liver Disease.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: December 17, 2024

AMPK phosphorylation of KCa2.3 alleviates angiotensin II-induced endothelial dysfunction.

AMPK phosphorylation of KCa2.3 alleviates angiotensin II-induced endothelial dysfunction.

Journal: Biochemical pharmacology

Published: July 24, 2024

YAP-galectin-3 signaling mediates endothelial dysfunction in angiotensin II-induced hypertension in mice.

YAP-galectin-3 signaling mediates endothelial dysfunction in angiotensin II-induced hypertension in mice.

Journal: Cellular and molecular life sciences : CMLS

Published: July 20, 2022

Roles of Yes-associated protein and transcriptional coactivator with PDZ-binding motif in non-neoplastic liver diseases.

Roles of Yes-associated protein and transcriptional coactivator with PDZ-binding motif in non-neoplastic liver diseases.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 04, 2022

Genetically modified rabbit models for cardiovascular medicine.

Genetically modified rabbit models for cardiovascular medicine.

Journal: European journal of pharmacology

Published: January 08, 2022

Inhibitors of the MAPK/ NF-κB pathway attenuate the upregulation of the ETB receptor mediated by high glucose in vascular smooth muscle cells.

Inhibitors of the MAPK/ NF-κB pathway attenuate the upregulation of the ETB receptor mediated by high glucose in vascular smooth muscle cells.

Journal: Peptides

Published: October 10, 2021

Calcitriol Suppressed Isoproterenol-induced Proliferation of Cardiac Fibroblasts via Integrin β3/FAK/Akt Pathway.

Calcitriol Suppressed Isoproterenol-induced Proliferation of Cardiac Fibroblasts via Integrin β3/FAK/Akt Pathway.

Journal: Current medical science

Published: June 10, 2021

Angiotensin II upregulates endothelin receptors through the adenosine monophosphate-activated protein kinase/sirtuin 1 pathway in vascular smooth muscle cells.

Angiotensin II upregulates endothelin receptors through the adenosine monophosphate-activated protein kinase/sirtuin 1 pathway in vascular smooth muscle cells.

Journal: The Journal of pharmacy and pharmacology

Published: May 23, 2021

AMPK upregulates KCa2.3 channels and ameliorates endothelial dysfunction in diet-induced obese mice.

AMPK upregulates KCa2.3 channels and ameliorates endothelial dysfunction in diet-induced obese mice.

Journal: Biochemical pharmacology

Published: July 22, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026